Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9005736 | Clinical Therapeutics | 2005 | 20 Pages |
Abstract
Telithromycin appears to be a useful option for the empiric treatment of community-acquired RTIs in adults. It may be particularly useful in the outpatient setting in areas with high rates of penicillin- and macrolide-resistant S pneumoniae; it may also be an alternative agent for patients who are allergic to β-lactams and live in areas with a high prevalence of multidrug-resistant S pneumoniae or for those who have failed to respond to β-lactam- or macrolide-based therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
PharmD Nguyen, PharmD Chung,